The present invention concerns methods of treating systemic, regional, or local inflammation from a patient suffering or at risk of inflammation comprising administration of a therapeutically effective dose of a sorbent that sorbs an inflammatory mediator in said patient. In some preferred embodiments, the sorbent is a biocompatible organic polymer.

The present invention concerns methods of treating systemic, regional, or local inflammation from a patient suffering or at risk of inflammation comprising administration of a therapeutically effective dose of a sorbent that sorbs an inflammatory mediator in said patient. In some preferred embodiments, the sorbent is a biocompatible organic polymer.

A material composition including a matrix including a first material, the matrix including a plurality of voids disposed in the matrix, two or more voids being spaced apart from each other, a plurality of elongate fibers of a second material located within the matrix, wherein the plurality of fibers are configured to reinforce the matrix and, wherein the material composition is a composite material composition.

A rigid flow control device includes a porous rigid body having an outer surface and an inner surface. The body defines a flow path and is formed from a material operatively arranged with a surface energy less than that of the fluid for passively impeding an undesirable component of the fluid more than a desirable component of the fluid.

A method of manufacturing a flexible intrinsically antimicrobial absorbent porosic composite controlling for an effective pore size using removable pore-forming substances and physically incorporated, non-leaching antimicrobials. A flexible intrinsically antimicrobial absorbent porosic composite controlled for an effective pore size composited physically incorporated, high-surface area, non-leaching antimicrobials, optionally in which the physically incorporated non-leaching antimicrobial exposes nanopillars on its surface to enhance antimicrobial activity. A kit that enhances the effectiveness of the intrinsically antimicrobial absorbent porosic composite by storing the composite within an antimicrobial container.

Provided is an oriented multilayer porous film comprising at least one layer comprising: a heat, solvent, and degradation resistant matrix polymer; a plurality of interconnecting pores; and a porosity less than 90%. The film is made by a dry and/or wet method, with its multilayer structure constructed by coextrusion, lamination, and coating. The film of this disclosure finds a wide range of applications as a permselective medium for use in energy harvesting and storage, filtration, separation and purification of gases and fluids, CO.sub.2 and volatile capture, electronics, devices, structural supports, packaging, labeling, printing, clothing, drug delivery systems, bioreactor, and the like. The film is preferably used as a separator of lithium-ion, lithium-sulfur, lithium-air, metal-air, and nonaqueous electrolyte batteries.

The present invention relate to three dimensional porous polysaccharide matrices able to induce mineralisation of a tissue in osseous site, as well as in non-osseous site, in the absence of stem cells or growth factors.

The present invention provides for concentrated aqueous silk fibroin solutions and an all-aqueous mode for preparation of concentrated aqueous fibroin solutions that avoids the use of organic solvents, direct additives, or harsh chemicals. The invention further provides for the use of these solutions in production of materials, e.g., fibers, films, foams, meshes, scaffolds and hydrogels.

The present invention concerns methods of treating systemic, regional, or local inflammation from a patient suffering or at risk of inflammation comprising administration of a therapeutically effective dose of a sorbent that sorbs an inflammatory mediator in said patient. In some preferred embodiments, the sorbent is a biocompatible organic polymer.

The present invention provides for concentrated aqueous silk fibroin solutions and an all-aqueous mode for preparation of concentrated aqueous fibroin solutions that avoids the use of organic solvents, direct additives, or harsh chemicals. The invention further provides for the use of these solutions in production of materials, e.g., fibers, films, foams, meshes, scaffolds and hydrogels.